A detailed history of Saratoga Research & Investment Management transactions in Medtronic PLC stock. As of the latest transaction made, Saratoga Research & Investment Management holds 1,390,900 shares of MDT stock, worth $124 Million. This represents 4.98% of its overall portfolio holdings.

Number of Shares
1,390,900
Previous 1,367,919 1.68%
Holding current value
$124 Million
Previous $119 Million 8.17%
% of portfolio
4.98%
Previous 5.42%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 16, 2024

BUY
$78.71 - $87.02 $1.81 Million - $2 Million
22,981 Added 1.68%
1,390,900 $109 Million
Q1 2024

Apr 17, 2024

BUY
$82.84 - $88.09 $8.89 Million - $9.46 Million
107,345 Added 8.52%
1,367,919 $119 Million
Q4 2023

Feb 09, 2024

SELL
$69.43 - $83.43 $2.63 Million - $3.15 Million
-37,814 Reduced 2.91%
1,260,574 $104 Million
Q3 2023

Nov 09, 2023

BUY
$78.22 - $90.4 $9.39 Million - $10.9 Million
120,053 Added 10.19%
1,298,388 $102 Million
Q2 2023

Jul 24, 2023

BUY
$79.47 - $91.38 $3.38 Million - $3.89 Million
42,532 Added 3.74%
1,178,335 $104 Million
Q1 2023

May 05, 2023

BUY
$76.72 - $87.58 $11.1 Million - $12.7 Million
145,080 Added 14.64%
1,135,803 $91.6 Million
Q4 2022

Feb 13, 2023

SELL
$76.18 - $87.74 $2.54 Million - $2.93 Million
-33,341 Reduced 3.26%
990,723 $77 Million
Q3 2022

Oct 31, 2022

BUY
$80.75 - $95.31 $12 Million - $14.2 Million
148,777 Added 17.0%
1,024,064 $82.7 Million
Q2 2022

Aug 01, 2022

BUY
$87.4 - $113.09 $10 Million - $12.9 Million
114,469 Added 15.05%
875,287 $78.6 Million
Q1 2022

Apr 29, 2022

BUY
$100.58 - $112.38 $21.7 Million - $24.2 Million
215,306 Added 39.47%
760,818 $84.4 Million
Q4 2021

Feb 08, 2022

BUY
$99.53 - $127.75 $556,074 - $713,739
5,587 Added 1.03%
545,512 $56.4 Million
Q3 2021

Nov 05, 2021

SELL
$122.75 - $135.17 $189,771 - $208,972
-1,546 Reduced 0.29%
539,925 $67.7 Million
Q2 2021

Aug 10, 2021

SELL
$118.19 - $131.5 $188,631 - $209,874
-1,596 Reduced 0.29%
541,471 $67.2 Million
Q1 2021

Apr 12, 2021

BUY
$111.18 - $119.74 $27,127 - $29,216
244 Added 0.04%
543,067 $64.2 Million
Q4 2020

Feb 03, 2021

BUY
$100.57 - $117.14 $1.02 Million - $1.19 Million
10,159 Added 1.91%
542,823 $63.6 Million
Q3 2020

Oct 09, 2020

SELL
$90.13 - $108.78 $1.26 Million - $1.52 Million
-13,985 Reduced 2.56%
532,664 $55.4 Million
Q2 2020

Aug 07, 2020

BUY
$84.11 - $103.33 $1.17 Million - $1.44 Million
13,920 Added 2.61%
546,649 $50.1 Million
Q1 2020

May 13, 2020

BUY
$72.92 - $121.3 $10.5 Million - $17.4 Million
143,807 Added 36.98%
532,729 $48 Million
Q4 2019

Feb 05, 2020

SELL
$104.49 - $114.54 $268,643 - $294,482
-2,571 Reduced 0.66%
388,922 $44.1 Million
Q3 2019

Oct 29, 2019

SELL
$98.02 - $111.18 $964,320 - $1.09 Million
-9,838 Reduced 2.45%
391,493 $42.5 Million
Q2 2019

Jul 24, 2019

BUY
$84.15 - $99.38 $1.08 Million - $1.27 Million
12,795 Added 3.29%
401,331 $39.1 Million
Q1 2019

Apr 18, 2019

BUY
$82.45 - $93.79 $171,413 - $194,989
2,079 Added 0.54%
388,536 $35.4 Million
Q4 2018

Jan 15, 2019

SELL
$85.8 - $99.49 $1.98 Million - $2.29 Million
-23,057 Reduced 5.63%
386,457 $35.2 Million
Q3 2018

Oct 15, 2018

SELL
$85.91 - $99.17 $1.59 Million - $1.84 Million
-18,528 Reduced 4.33%
409,514 $40.3 Million
Q2 2018

Jul 17, 2018

BUY
$77.48 - $87.83 $5.54 Million - $6.28 Million
71,449 Added 20.04%
428,042 $36.6 Million
Q1 2018

May 01, 2018

BUY
$76.55 - $87.26 $289,894 - $330,453
3,787 Added 1.07%
356,593 $28.6 Million
Q4 2017

Jan 19, 2018

SELL
$76.93 - $83.5 $960,163 - $1.04 Million
-12,481 Reduced 3.42%
352,806 $28.5 Million
Q3 2017

Oct 24, 2017

BUY
$77.71 - $84.6 $28.4 Million - $30.9 Million
365,269 Added 2029272.25%
365,287 $28.4 Million
Q3 2017

Oct 24, 2017

BUY
$77.71 - $84.6 $1,398 - $1,522
18
18 $1,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $119B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Saratoga Research & Investment Management Portfolio

Follow Saratoga Research & Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saratoga Research & Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Saratoga Research & Investment Management with notifications on news.